A pilot study evaluating the safety, tolerability, and efficacy of doxorubicin and pembrolizumab in patients with metastatic or unresectable soft tissue sarcoma.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Levine Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck Sharp and Dohme
OpenAlex ID: W3030891675
